drugset
drugset / Trial / NCT04713969

Neuro-immune Interactions and PPI

NCT04713969 ↗

Phase 4 Completed 60 enrolled Universitaire Ziekenhuizen KU Leuven
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Prospective interventional study on duodenal neuro-immune interactions in healthy volunteers and functional dyspepsia patients and the effects of PPI

Timeline

Start
2021-03-31
Primary completion
2024-01-10
Completion
2024-09-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Pantoprazole Other / unclassified 40 mg —

Indications

dyspepsia